176 related articles for article (PubMed ID: 24857573)
1. Follicular lesions of the thyroid.
Mathur A; Olson MT; Zeiger MA
Surg Clin North Am; 2014 Jun; 94(3):499-513. PubMed ID: 24857573
[TBL] [Abstract][Full Text] [Related]
2. Follicular thyroid lesions, elements that affect both diagnosis and prognosis.
Zeiger MA; Dackiw AP
J Surg Oncol; 2005 Mar; 89(3):108-13. PubMed ID: 15719377
[TBL] [Abstract][Full Text] [Related]
3. Follicular neoplasm of the thyroid--vanishing cytologic diagnosis?
Kapur U; Wojcik EM
Diagn Cytopathol; 2007 Aug; 35(8):525-8. PubMed ID: 17636488
[TBL] [Abstract][Full Text] [Related]
4. Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application.
Saggiorato E; De Pompa R; Volante M; Cappia S; Arecco F; Dei Tos AP; Orlandi F; Papotti M
Endocr Relat Cancer; 2005 Jun; 12(2):305-17. PubMed ID: 15947105
[TBL] [Abstract][Full Text] [Related]
5. Immunostaining for Met/HGF receptor may be useful to identify malignancies in thyroid lesions classified suspicious at fine-needle aspiration biopsy.
Ippolito A; Vella V; La Rosa GL; Pellegriti G; Vigneri R; Belfiore A
Thyroid; 2001 Aug; 11(8):783-7. PubMed ID: 11525273
[TBL] [Abstract][Full Text] [Related]
6. Clinical presentation of patients with a thyroid follicular neoplasm: are there preoperative predictors of malignancy?
Najafian A; Olson MT; Schneider EB; Zeiger MA
Ann Surg Oncol; 2015 Sep; 22(9):3007-13. PubMed ID: 25564170
[TBL] [Abstract][Full Text] [Related]
7. Preoperative diagnosis of the follicular variant of papillary carcinoma of the thyroid: discrepancy between image and cytologic diagnoses.
Komatsu M; Hanamura N; Tsuchiya S; Seki T; Kuroda T
Radiat Med; 1994; 12(6):293-9. PubMed ID: 7724824
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of the thyroid peroxidase marker for distinguishing follicular thyroid carcinoma from follicular adenoma.
Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
Exp Oncol; 2006 Mar; 28(1):70-4. PubMed ID: 16614712
[TBL] [Abstract][Full Text] [Related]
9. Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns.
Eszlinger M; Paschke R
Mol Cell Endocrinol; 2010 Jun; 322(1-2):29-37. PubMed ID: 20083161
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of distinguishing between follicular lesion and follicular neoplasm in thyroid fine-needle aspiration biopsy.
Williams MD; Suliburk JW; Staerkel GA; Busaidy NL; Clayman GL; Evans DB; Perrier ND
Ann Surg Oncol; 2009 Nov; 16(11):3146-53. PubMed ID: 19727961
[TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinase-2, but not caspase-3, facilitates distinction between benign and malignant thyroid follicular neoplasms.
Sanii S; Saffar H; Tabriz HM; Qorbani M; Haghpanah V; Tavangar SM
Asian Pac J Cancer Prev; 2012; 13(5):2175-8. PubMed ID: 22901190
[TBL] [Abstract][Full Text] [Related]
12. [Fine-needle aspiration biopsy of the thyroid nodule: uses and limitations].
Hayashi N; Kitaoka M
Nihon Rinsho; 2007 Nov; 65(11):2003-7. PubMed ID: 18018562
[TBL] [Abstract][Full Text] [Related]
13. Thyroid neoplasms of follicular cell derivation: a simplified approach.
Asa SL; Mete O
Semin Diagn Pathol; 2013 Aug; 30(3):178-85. PubMed ID: 24144287
[TBL] [Abstract][Full Text] [Related]
14. The use of a combination of Ki-67, Galectin-3, and PTTG can distinguish the benign and malignant thyroid tumor.
Cui W; Lu X; Zheng S; Ma Y; Liu X; Zhang W
Clin Lab; 2012; 58(5-6):419-26. PubMed ID: 22783570
[TBL] [Abstract][Full Text] [Related]
15. HBME-1 expression in follicular tumor of the thyroid: an investigation of whether it can be used as a marker to diagnose follicular carcinoma.
Ito Y; Yoshida H; Tomoda C; Miya A; Kobayashi K; Matsuzuka F; Kakudo K; Kuma K; Miyauchi A
Anticancer Res; 2005; 25(1A):179-82. PubMed ID: 15816536
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity: a marker to distinguish follicular thyroid adenoma from carcinoma.
Umbricht CB; Saji M; Westra WH; Udelsman R; Zeiger MA; Sukumar S
Cancer Res; 1997 Jun; 57(11):2144-7. PubMed ID: 9187112
[TBL] [Abstract][Full Text] [Related]
17. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
18. Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators.
Than TH; Swethadri GK; Wong J; Ahmad T; Jamil D; Maganlal RK; Hamdi MM; Abdullah MS
Singapore Med J; 2008 Apr; 49(4):333-8. PubMed ID: 18418527
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of survivin expression in thyroid follicular adenoma and carcinoma.
Haghpanah V; Shooshtarizadeh P; Heshmat R; Larijani B; Tavangar SM
Appl Immunohistochem Mol Morphol; 2006 Dec; 14(4):422-5. PubMed ID: 17122639
[TBL] [Abstract][Full Text] [Related]
20. Fine-needle aspiration of follicular patterned lesions of the thyroid: Diagnosis, management, and follow-up according to National Cancer Institute (NCI) recommendations.
Faquin WC; Baloch ZW
Diagn Cytopathol; 2010 Oct; 38(10):731-9. PubMed ID: 20049964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]